1 recruiting, 1 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 1, Unknown 1 |
Follow Relapse Multiple Myeloma: new trials by email Literature Review of Relapse Multiple Myeloma trials Research Report on Relapse Multiple Myeloma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Comparing Therapy for Advanced Relapsed/Refractory Multiple Myeloma With and Without Dexamethasone Dexamethasone - Multiple Myeloma, Relapse Multiple Myeloma | Phase 3 | Recruiting | Assistance Publique - Hôpitaux de Paris | 318 | 2024-12-12 | 2024-12-18 |
| Pomalidomide-Cyclophosphamide-Dexamethasone (PCD) Versus Pomalidomide-Dexamethasone (PD) in Relapse or Refractory Myeloma PCD, PD - Relapse Multiple Myeloma | Phase 3 | Unknown | National University Hospital, Singapore | 120 | 2017-09-13 | 2017-11-06 |
Multiple Myeloma (1) · Recurrence (1)
Blood Protein Disorders (1) · Cardiovascular Diseases (1) · Disease Attributes (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Plasma Cell (1) · Paraproteinemias (1) · Pathologic Processes (1)
Dexamethasone (1)
Assistance Publique - Hôpitaux de Paris (1) · National University Hospital, Singapore (1)
France (1) · Hong Kong (1) · Japan (1) · Singapore (1) · South Korea (1) · Taiwan (1)
Wee Joo Chng (1)